(Q48506093)

12 February 2018

title

An open label pilot study of citalopram for depression and boredom in ambulatory cancer patients (English)

1 reference

12 February 2018

author name string

Dale E Theobald

1

1 reference

12 February 2018

Kenneth L Kirsh

2

1 reference

12 February 2018

Elizabeth Holtsclaw

3

1 reference

12 February 2018

Kathleen Donaghy

4

1 reference

12 February 2018

Steven D Passik

5

1 reference

12 February 2018

publication date

1 March 2003

1 reference

12 February 2018

Palliative and Supportive Care

published in

1 reference

12 February 2018

volume

1

1 reference

12 February 2018

issue

1

1 reference

12 February 2018

page(s)

71-77

1 reference

12 February 2018

Use of a depression screening tool and a fluoxetine-based algorithm to improve the recognition and treatment of depression in cancer patients. A demonstration project

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1478951503030037

7 January 2021

The Functional Assessment of Cancer Therapy scale: development and validation of the general measure

1 reference

https://api.crossref.org/works/10.1017%2FS1478951503030037

7 January 2021

Pilot evaluation of venlafaxine for the treatment of hot flashes in men undergoing androgen ablation therapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1017%2FS1478951503030037

7 January 2021

The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress.

1 reference

https://api.crossref.org/works/10.1017%2FS1478951503030037

7 January 2021

Temporal interrelationships among fatigue, circadian rhythm and depression in breast cancer patients undergoing chemotherapy treatment

1 reference

https://api.crossref.org/works/10.1017%2FS1478951503030037

7 January 2021

A SELF-RATING DEPRESSION SCALE

1 reference

https://api.crossref.org/works/10.1017%2FS1478951503030037

7 January 2021

Initial validation of a scale to measure purposelessness, understimulation, and boredom in cancer patients: toward a redefinition of depression in advanced disease.

1 reference

https://api.crossref.org/works/10.1017%2FS1478951503030037

7 January 2021

Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1017%2FS1478951503030037

7 January 2021

Oncologists' recognition of depression in their patients with cancer

1 reference

https://api.crossref.org/works/10.1017%2FS1478951503030037

7 January 2021

Use of the Zung Self-Rating Depression Scale in cancer patients: feasibility as a screening tool

1 reference

https://api.crossref.org/works/10.1017%2FS1478951503030037

7 January 2021

10.1017/S1478951503030037

Identifiers

DOI

1 reference

12 February 2018

1 reference

12 February 2018